Skip to main content
Log in

Primary Cutaneous Plasmacytoma after Rejection of a Transplanted Kidney: Case Report and Review of the Literature

  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Immunosuppressed organ allograft recipients are at risk of developing lymphomas and lymphoproliferative disorders as a consequence of immunosuppressive therapy and long-term antigenic stimulation from both the graft and possible viral infections. No more than 4% of the malignant tumors detected in organ recipients are plasmacytomas. Primary cutaneous plasmacytoma is a rare type of cutaneous B-cell lymphoma arising primarily in the skin. It is derived from clonally expanded plasma cells with various degrees of maturation and atypia. We report the occurrence of a solitary cutaneous plasmacytoma in a 56-year-old male patient undergoing hemodialysis after rejection of a grafted kidney. The diagnosis was made a few months after the kidney had been surgically removed. A thorough examination showed no evidence of systemic disease. Skin lesions were successfully treated with local radiotherapy. After 2 years of follow-up there were no local or systemic recurrences.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Penn I. Some problems with posttransplant lymphoproliferative disease. Transplantation. 2000;69:705–706.

    Article  PubMed  CAS  Google Scholar 

  2. Fischer T, Miller M, Bott-Silverman C, Lichtin A. Posttransplant lymphoproliferative disease after cardiac transplantation. Transplantation. 1996;62:1687–1690.

    Article  PubMed  CAS  Google Scholar 

  3. Swerdlow AJ, Higgins CD, Hunt BJ, et al. Risk of lymphoid neoplasia after cardiothoracic transplantation. Transplantation. 2000; 69:897–904.

    Article  PubMed  CAS  Google Scholar 

  4. Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodg- kin’s disease. Lancet. 1991;337:320–322.

    Article  PubMed  CAS  Google Scholar 

  5. Tuting T, Bork K. Primary plasmacytoma of the skin. J Am Acad Dermatol. 1996;34:386–390.

    Article  PubMed  CAS  Google Scholar 

  6. Muscardin L, Pulsoni A, Cerroni L. Primary cutaneous plasmacytoma: report of a case with review of the literature. J Am Acad Dermatol. 2000;43:962–965.

    Article  PubMed  CAS  Google Scholar 

  7. Wong KF, Chan JKC, Li LPK, Yau TK. Primary cutaneous plasmacytoma: report of two cases and review of the literature. Am J Dermatopathol. 1994;16:392–397.

    Article  PubMed  CAS  Google Scholar 

  8. Kazakov DV, Belousova IE, Muller B, et al. Primary cutaneous plasmacytoma: a clinicopathological study of two cases with a longterm follow-up and review of the literature. J Cutan Pathol. 2002; 29:244–248.

    Article  PubMed  Google Scholar 

  9. Maisonneuve P, Agodoa L, Gellert R, et al. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet. 1999;354:93–99.

    Article  PubMed  CAS  Google Scholar 

  10. Bierkland SA, Lokkegaard H, Storm HH. Cancer in patients on dialysis and after renal transplantation. Lancet. 2000;355:1886–1887.

    Article  Google Scholar 

  11. Opelz G, Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet. 1993;342:1514–1516.

    Article  PubMed  CAS  Google Scholar 

  12. Hanto DW, Simmons RI. Lymphoproliferative diseases in immuno-suppressed patients. In: Morris PJ, Tinley NL, eds. Progress in Transplantation. Edinburgh, UK: Churchill Livingstone; 1984:170–192.

    Google Scholar 

  13. Penn I. Letter to the editor. Am J Kidney Dis. 1988;11:201.

    Article  PubMed  CAS  Google Scholar 

  14. Penn I. Post-transplant malignancy: the role of immunosuppression. Drug Saf. 2000;23:101–112.

    Article  PubMed  CAS  Google Scholar 

  15. York LJ, Qualtiere LF. Cyclosporine abrogates virus-specific T cell control of EB V-induced B cell lymphoproliferation. Viral Immunol. 1990;3:127–136.

    Article  PubMed  CAS  Google Scholar 

  16. Zanazzi M, Bertoni E, Di Maria L, Rosati A, Tosi B, Salvadori M. Malignancies in renal transplant patients: etiopathogenetic, epidemiological and prevention aspects. Ital J Nephrol. 1999;16:564–575.

    Google Scholar 

  17. Dotti G, Fiocchi R, Motta T, et al. Epstein Barr virus-negative lymphoproliferative disorders in long-term survivors after heart, kidney and liver transplant. Transplantation. 2000;69:827–833.

    Article  PubMed  CAS  Google Scholar 

  18. Joseph G, Barker RL, Yuan B, Martin A, Medeiros J, Peiper SC. Post-transplantation plasma cell dyscrasias. Cancer. 1994;7:1959–1964.

    Article  Google Scholar 

  19. Rees L, Amlot PL. Disappearance of an Epstein Barr virus-positive post-transplant plasmacytoma with reduction of immunosuppression. Lancet. 1998;352:789.

    Article  PubMed  CAS  Google Scholar 

  20. Nalesnik MA, Starzl TE. Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders. Transplant Sci. 1994;4:61–79.

    PubMed  PubMed Central  CAS  Google Scholar 

  21. Knowles DM. Immunodeficiency-associated lymphoproliferative disorders. Mol Pathol. 1999;12:200–217.

    CAS  Google Scholar 

  22. Leigh BR, Larkin EC, Scotte Doggett RL. Solitary extramedullary plasmacytoma five years after successful cardiac transplantation. Am J Clin Oncol. 1997;20:467–470.

    Article  PubMed  CAS  Google Scholar 

  23. Melato M, Paladini G. Multiple myeloma following reactivated Epstein Barr virus infection in a renal transplant recipient. Haematologica. 1986;71:241–243.

    PubMed  CAS  Google Scholar 

  24. Whittam LR, Coleman R, MacDonald DM. Plasma cell tumour in a renal transplant recipient. Clin Exp Dermatol. 1996;21:367–369.

    Article  PubMed  CAS  Google Scholar 

  25. Aparicio M, De Precigout V, Reiffers J, et al. Multiple myeloma and AL amyloidosis in a renal transplant recipient. Nephron. 1989; 53:373–375.

    Article  PubMed  CAS  Google Scholar 

  26. Falkmer U, Jarhult J, Wersall P, Cavallin-Stahl E. A systematic overview of radiation therapy effects in skeletal metastases. Acta Oncol. 2003;42:620–633.

    Article  PubMed  Google Scholar 

  27. Gregory WM, Richards MA, Malpas JS. Combined chemotherapy versus melphalan and prednisolone for treatment of myelomatosis. Lancet. 1992;339:1353–1354.

    Article  PubMed  CAS  Google Scholar 

  28. Myeloma Trialists’ Collaborative Group. Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. J Clin Oncol. 1998;16:3832–3842.

    Article  Google Scholar 

  29. Rosen LS, Gordon D, Kaminski M, et al. Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial. Cancer. 2003;15:1735–1744.

    Article  CAS  Google Scholar 

  30. Rego F, Alcantara P, Buinho F, et al. Autologous peripheral stem cell transplantation for multiple myeloma in a patient with a 10 year-old kidney transplant: case report and clinical issues. Transplant Proc. 2003;35:1102–1104.

    Article  PubMed  CAS  Google Scholar 

  31. Stachel D, Schmid I, Lang T, Haas RJ, Otte JB. Double bone marrow transplantation for severe aplastic anemia after orthotopic liver transplantation: implications for clinical management and immune tolerance. Transpl Int. 2002;15:39–44.

    Article  PubMed  Google Scholar 

  32. Dey B, Sykes M, Spitzer TR. Outcomes of recipients of both bone marrow and solid organ transplants: a review. Medicine (Baltimore). 1998;77:355–369.

    Article  CAS  Google Scholar 

  33. Perkins JL, Neglia JP, Ramsay NK, Davies SM. Successful bone marrow transplantation for severe aplastic anemia following orthotopic liver transplantation: long-term follow-up and outcome. Bone Marrow Transplant. 2001;28:523–526.

    Article  PubMed  CAS  Google Scholar 

  34. Mahe B, Moreau P, Le Tortorec S, Hourmant M, Harousseau JL, Milpied N. Autologous bone marrow transplantation for cyclosporin- related lymphoma in a renal transplant patient. Bone Marrow Transplant. 1994;14:645–646.

    PubMed  CAS  Google Scholar 

  35. Au WY, Lie AKW, Chan EC, et al. Treatment of postrenal transplantation lymphoproliferative disease manifesting as plasmacytoma with nonmyeloablative hematopoietic stem cell transplantation from the same kidney donor. Am J Hematol. 2003;74:283–286.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gianpaolo Tessari.

About this article

Cite this article

Tessari, G., Fabbian, F., Colato, C. et al. Primary Cutaneous Plasmacytoma after Rejection of a Transplanted Kidney: Case Report and Review of the Literature. Int J Hematol 80, 361–364 (2004). https://doi.org/10.1532/IJH97.E0406

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1532/IJH97.E0406

Key words

Navigation